share_log

Azitra Shares Are Trading Higher After the Company Received FDA Approval to Proceed With Its Phase 1/2 Clinical Study of ATR-04.

Benzinga ·  Aug 23 00:18
Azitra Shares Are Trading Higher After the Company Received FDA Approval to Proceed With Its Phase 1/2 Clinical Study of ATR-04.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment